143 related articles for article (PubMed ID: 30849003)
21. Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative data.
Fisher BT; Harris T; Torp K; Seif AE; Shah A; Huang YS; Bailey LC; Kersun LS; Reilly AF; Rheingold SR; Walker D; Li Y; Aplenc R
Med Care; 2014 Jan; 52(1):e1-6. PubMed ID: 22410405
[TBL] [Abstract][Full Text] [Related]
22. Overweight and obesity as predictors of early mortality in Mexican children with acute lymphoblastic leukemia: a multicenter cohort study.
Núñez-Enríquez JC; Gil-Hernández AE; Jiménez-Hernández E; Fajardo-Gutiérrez A; Medina-Sansón A; Flores-Lujano J; Espinoza-Hernández LE; Duarte-Rodríguez DA; Amador-Sánchez R; Peñaloza-González JG; Torres-Nava JR; Espinosa-Elizondo RM; Flores-Villegas LV; Merino-Pasaye LE; Pérez-Saldivar ML; Dorantes-Acosta EM; Cortés-Herrera B; Solis-Labastida KA; Núñez-Villegas NN; Velázquez-Aviña MM; Rangel-López A; González-Ávila AI; Santillán-Juárez JD; García-Velázquez AJ; Jiménez-Morales S; Bekker-Méndez VC; Rosas-Vargas H; Mata-Rocha M; Sepúlveda-Robles OA; Martín-Trejo JA; Mejía-Aranguré JM
BMC Cancer; 2019 Jul; 19(1):708. PubMed ID: 31319816
[TBL] [Abstract][Full Text] [Related]
23. Physical Therapy Utilization Among Hospitalized Patients With Pediatric Acute Lymphoblastic Leukemia.
Rodwin RL; Ma X; Ness KK; Kadan-Lottick NS; Wang R
JCO Oncol Pract; 2022 Jul; 18(7):e1060-e1068. PubMed ID: 35427182
[TBL] [Abstract][Full Text] [Related]
24. Adolescents with acute lymphoblastic leukemia treated at pediatric versus adult hospitals.
Pole JD; Alibhai SM; Ethier MC; Teuffel O; Portwine C; Zelcer S; Johnston DL; Silva M; Alexander S; Brandwein JM; Sung L
Ann Oncol; 2013 Mar; 24(3):801-6. PubMed ID: 23108950
[TBL] [Abstract][Full Text] [Related]
25. Access to Hematopoietic Stem Cell Transplantation among Pediatric Patients with Acute Lymphoblastic Leukemia: A Population-Based Analysis.
Truong TH; Pole JD; Bittencourt H; Schechter T; Cuvelier GDE; Paulson K; Rayar M; Mitchell D; Schultz KR; O'Shea D; Barber R; Wall D; Sung L
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1172-1178. PubMed ID: 30769192
[TBL] [Abstract][Full Text] [Related]
26. Health conditions associated with metabolic syndrome after cancer at a young age: A nationwide register-based study.
Kero AE; Madanat-Harjuoja LM; Järvelä LS; Malila N; Matomäki J; Lähteenmäki PM
Cancer Epidemiol; 2016 Apr; 41():42-9. PubMed ID: 26816350
[TBL] [Abstract][Full Text] [Related]
27. Treatment-related toxicities associated with hospitalization in children, adolescents, and young adults with acute lymphoblastic leukemia: population level analysis.
Namjoshi NS; Keegan THM; Li QC; Chung JH; Rosenthal JL; Winestone LE; Muffly L; Malogolowkin MH; Alvarez EM
Leuk Lymphoma; 2022 Dec; 63(13):3191-3199. PubMed ID: 35999808
[TBL] [Abstract][Full Text] [Related]
28. Real-World Cost of Pediatric Acute Lymphoblastic Leukemia Care Among Commercially Insured Individuals in the United States: Effect of Era and Age at Diagnosis.
Turcotte LM; Watson D; Tanner L; Hoover A; Gilchrist L; Finch M; Messinger YH
JCO Oncol Pract; 2022 Nov; 18(11):e1750-e1761. PubMed ID: 36166724
[TBL] [Abstract][Full Text] [Related]
29. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
30. Birth weight and other risk factors for acute leukemia in the Jerusalem Perinatal Study cohort.
Paltiel O; Harlap S; Deutsch L; Knaanie A; Massalha S; Tiram E; Barchana M; Friedlander Y
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1057-64. PubMed ID: 15184264
[TBL] [Abstract][Full Text] [Related]
31. Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden.
Katz AJ; Chia VM; Schoonen WM; Kelsh MA
Cancer Causes Control; 2015 Nov; 26(11):1627-42. PubMed ID: 26376890
[TBL] [Abstract][Full Text] [Related]
32. Clinical management of Australian adolescents and young adults with acute lymphoblastic and myeloid leukemias: A national population-based study.
White VM; Skaczkowski G; Pinkerton R; Coory M; Osborn M; Bibby H; Nicholls W; Orme LM; Conyers R; Phillips MB; Harrup R; Walker R; Thompson K; Anazodo A
Pediatr Blood Cancer; 2018 Nov; 65(11):e27349. PubMed ID: 30039912
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Overall Survival Between De Novo and Secondary Acute Lymphoblastic Leukemia Patients of Different Ages.
Zhong J; Yu X; Zhang X
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e622-e627. PubMed ID: 32565127
[TBL] [Abstract][Full Text] [Related]
34. Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
Meeske KA; Ji L; Freyer DR; Gaynon P; Ruccione K; Butturini A; Avramis VI; Siegel S; Matloub Y; Seibel NL; Sposto R
Pediatr Blood Cancer; 2015 Dec; 62(12):2140-9. PubMed ID: 26173904
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular medication after cancer at a young age in Finland: A nationwide registry linkage study.
Kero AE; Madanat-Harjuoja LM; Järvelä LS; Malila N; Matomäki J; Lähteenmäki PM
Int J Cancer; 2016 Aug; 139(3):683-90. PubMed ID: 26610262
[TBL] [Abstract][Full Text] [Related]
36. Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon.
Muwakkit S; Al-Aridi C; Samra A; Saab R; Mahfouz RA; Farra C; Jeha S; Abboud MR
Am J Hematol; 2012 Jul; 87(7):678-83. PubMed ID: 22565284
[TBL] [Abstract][Full Text] [Related]
37. Outcome of Pediatric Acute Lymphoblastic Leukemia: Sixty Years of Progress.
Demidowicz E; Pogorzała M; Łęcka M; Żołnowska H; Marjańska A; Kubicka M; Kuryło-Rafińska B; Czyżewski K; Dębski R; Kołtan A; Richert-Przygońska M; Styczyński J
Anticancer Res; 2019 Sep; 39(9):5203-5207. PubMed ID: 31519634
[TBL] [Abstract][Full Text] [Related]
38. No evidence of a trial effect in newly diagnosed pediatric acute lymphoblastic leukemia.
Koschmann C; Thomson B; Hawkins DS
Arch Pediatr Adolesc Med; 2010 Mar; 164(3):214-7. PubMed ID: 20194252
[TBL] [Abstract][Full Text] [Related]
39. Differential survival improvement for patients 20-29 years of age with acute lymphoblastic leukemia.
Pole JD; Darmawikarta D; Alibhai SM; Brandwein JM; Sung L
Leuk Res; 2013 Oct; 37(10):1258-64. PubMed ID: 23867057
[TBL] [Abstract][Full Text] [Related]
40. Risk of hospitalization among survivors of childhood and adolescent acute lymphoblastic leukemia compared to siblings and a general population sample.
Ou JY; Smits-Seemann RR; Kaul S; Fluchel MN; Sweeney C; Kirchhoff AC
Cancer Epidemiol; 2017 Aug; 49():216-224. PubMed ID: 28734233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
